Related Experiment Video

Updated: May 22, 2026

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression
06:29

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

Published on: January 31, 2025

Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma

Marcus Thomasson1, Håkan Hedman, Börje Ljungberg

  • 1Department of Radiation Sciences, Umeå University, SE-901 87, Umeå, Sweden. marcus.thomasson@onkologi.umu.se

BMC Research Notes
|May 5, 2012
PubMed
Abstract

Insights

Epidermal growth factor receptor (EGFR) and ERBB4 are altered in all renal cell carcinoma (RCC) types, while ERBB2 and LRIG1 changes are specific to clear cell RCC. These findings highlight the need for type-specific analysis of biomarkers in RCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Altered expression of epidermal growth factor receptor (EGFR)-family members and leucine-rich and immunoglobulin-like domains 1 (LRIG1) has been observed in renal cell carcinoma (RCC).
  • Understanding these alterations is crucial for identifying potential biomarkers and therapeutic targets in different RCC subtypes.

Purpose of the Study:

  • To analyze gene expression levels of EGFR-family members and LRIG1 in various RCC types.
  • To investigate the association between these gene expressions and clinical parameters in RCC patients.

Main Methods:

  • Quantitative real-time RT-PCR was used to analyze gene expression in 104 RCC samples (ccRCC, pRCC, chRCC).
  • Statistical assessment of associations between gene expression levels and clinical data (tumor grade, stage, survival).

Main Results:

  • EGFR was up-regulated in clear cell RCC (ccRCC) and papillary RCC (pRCC).
  • LRIG1, ERBB2, and ERBB4 were down-regulated in ccRCC; ERBB4 was significantly down-regulated across all RCC types.
  • ERBB3 expression showed no significant difference across RCC types or compared to kidney cortex. No correlation found between gene expression and patient outcome.

Conclusions:

  • Up-regulation of EGFR and down-regulation of ERBB4 are common across analyzed RCC types.
  • Down-regulation of ERBB2 and LRIG1 is specific to ccRCC, emphasizing the need for type-specific evaluation of biomarkers in renal cell carcinoma.

More Related Videos

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers12:22

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...